ProjectA 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab…
Basic data
Title:
A 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis
Duration:
19/10/2015 to 30/09/2018
Abstract / short description:
Klinische Studie
Keywords:
dermatology
Dermatologie
clinical trial
klinische Studie
psoriasis
Schuppenflechte
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Basingstoke, Hampshire, United Kingdom